Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. CM Hospitalar's Revenue for the
three
months ended in Mar. 2026 was R$2,832 Mil. CM Hospitalar's average Accounts Receivable for the
three
months ended in Mar. 2026 was R$1,958 Mil.
Hence, CM Hospitalar's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.45.
CM Hospitalar (BSP:VVEO3) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
CM Hospitalar Receivables Turnover Related Terms
CM Hospitalar Receivables Turnover Historical Data
* Premium members only.
The historical data trend for CM Hospitalar's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:VVEO3 vs MCK, CAH, COR: Receivables Turnover Comparison
For the Medical Distribution subindustry, CM Hospitalar's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CM Hospitalar Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CM Hospitalar's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where CM Hospitalar's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CM Hospitalar (BSP:VVEO3) has a Receivables Turnover of 1.45 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on CM Hospitalar and its competitors. According to the industry distribution chart, CM Hospitalar ranks #43 out of 118 companies in the Medical Distribution industry, placing it in the top 36.4%.
Is CM Hospitalar's Receivables Turnover too high?
CM Hospitalar's current Receivables Turnover is 1.45. The Medical Distribution industry median Receivables Turnover is 4.55. CM Hospitalar's value of 1.45 is 68.1% below this industry median. Based on the distribution chart, CM Hospitalar ranks #43 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, CM Hospitalar has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CM Hospitalar's Receivables Turnover compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, CM Hospitalar ranks #43 out of 118 companies for Receivables Turnover. This puts CM Hospitalar in the upper half of its industry. The industry median Receivables Turnover is 4.55. CM Hospitalar's value of 1.45 is 68.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.55, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CM Hospitalar's current Receivables Turnover of 1.45 is 68.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on CM Hospitalar and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CM Hospitalar's current Receivables Turnover is 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CM Hospitalar stock overvalued right now?
Based on GuruFocus' analysis, CM Hospitalar (BSP:VVEO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$1.99, compared to a current price of R$0.63 — trading 68.3% below its estimated fair value. The current Receivables Turnover is 1.45 and 68.1% below the Medical Distribution industry median of 4.55. CM Hospitalar's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For CM Hospitalar (BSP:VVEO3), the current Receivables Turnover is 1.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CM Hospitalar (BSP:VVEO3) Overvalued in 2026?
Based on GuruFocus' analysis, CM Hospitalar stock appears to be undervalued.
The current stock price of R$0.63 is trading 68.3% below its estimated GF Value™ of R$1.99.
GuruFocus considers CM Hospitalar to be Possible Value Trap.
Key valuation signals for BSP:VVEO3:
Receivables Turnover: 1.45
GF Value™: R$1.99 vs. price of R$0.63 (68.3% below fair value)
Industry Position: 68.1% below the Medical Distribution median (#43 of 118)
No single metric tells the full story. See the BSP:VVEO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:VVEO3 has been successfully added to your 
